Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Antenatal Support for Iron Deficiency Anemia
Sponsor: Thomas Jefferson University
Summary
This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.
Official title: Early Antenatal Support for Iron Deficiency Anemia: A Randomized Controlled Trial of Early Initiation of Intravenous Versus Oral Iron Therapy for Treatment of Iron Deficiency Anemia in Pregnancy
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2021-09-29
Completion Date
2026-12-30
Last Updated
2025-12-02
Healthy Volunteers
No
Interventions
Ferumoxytol
510mg infusion x 2 doses 3-8 days apart
Ferrous Sulfate
325mg oral twice daily
Locations (1)
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States